COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT

被引：0
|
作者：
Yi, Tae Won [1 ,2 ]
Atiquzzaman, Mohammad [3 ]
Zheng, Yuyan [3 ]
Smyth, Brendan [2 ,4 ]
Jardine, Meg [2 ,5 ]
Levin, Adeera [2 ,3 ,6 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[3] BC Prov Renal Agcy, Vancouver, BC, Canada
[4] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia
[5] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [41] Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease
    Heerspink, Hiddo J. L.
    Fouque, Denis
    Wanner, Christoph
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1 - 2
  • [42] Sodium-glucose cotransporter 2 inhibitors for chronic kidney disease: Why, when and when not
    Javaid, Muhammad M.
    Frederick, Rachel
    Itrat, Sheema
    Ekladious, Adel
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2024, 53 (12)
  • [43] Sodium-glucose cotransporter-2 inhibitor-associated thrombocytopenia
    Bando, Hironori
    Hirota, Yushi
    Ogawa, Wataru
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025, 24 (01): : 165 - 166
  • [44] Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study
    Liu, Jessica
    Chin-Yee, Benjamin
    Chin-Yee, Ian H.
    Ho, Jenny
    Sadikovic, Bekim
    Hsia, Cyrus C.
    JOURNAL OF INTERNAL MEDICINE, 2024, 295 (01) : 103 - 105
  • [45] Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes
    Mende, Christian W.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 541 - 551
  • [46] Sodium-glucose cotransporter 2 inhibitors and cardiorenal outcomes in kidney transplantation
    Mahalwar, Gauranga
    Mathew, Roy O.
    Rangaswami, Janani
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (01): : 53 - 60
  • [47] Renal Angiotensinogen and Sodium-Glucose Cotransporter-2 Inhibition: Insights from Experimental Diabetic Kidney Disease
    Burns, Kevin D.
    Cherney, David
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 49 (04) : 328 - 330
  • [48] Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease
    Vishwadeep Shelke
    Ajinath Kale
    Hans-Joachim Anders
    Anil Bhanudas Gaikwad
    Molecular and Cellular Biochemistry, 2023, 478 : 1987 - 1998
  • [49] Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium-Glucose Cotransporter-2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
    Xie, Yan
    Bowe, Benjamin
    Gibson, Andrew K.
    McGill, Janet B.
    Maddukuri, Geetha
    Al-Aly, Ziyad
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (11):
  • [50] Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease
    Shelke, Vishwadeep
    Kale, Ajinath
    Anders, Hans-Joachim
    Gaikwad, Anil Bhanudas
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (09) : 1987 - 1998
12345